Jane Street Group, LLC Vascular Biogenics Ltd. Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.11 - $0.16 $11,235 - $16,342	-102,138 Reduced 82.29%	21,989 $2,000
Q3 2022 Nov 14, 2022	BUY	$0.15 - $2.1 $18,619 - $260,666	124,127 New	124,127 $19,000
Q4 2021 Feb 15, 2022	SELL	$1.92 - $2.53 $39,093 - $51,513	-20,361 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$1.94 - $2.55 $39,500 - $51,920	20,361 New	20,361 $42,000
Q1 2019 May 16, 2019	SELL	$0.94 - $1.75 $9,701 - $18,061	-10,321 Closed	0 $0
Q4 2018 Feb 15, 2019	BUY	$0.6 - $1.72 $6,192 - $17,752	10,321 New	10,321 $10,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.